Semaglutide Launch Will Secure Early Position In India's GLP-1 Market

Shared on01 May 25
Fair value Increased 6.66%

Shared on24 Apr 25
Fair value Decreased 6.25%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on17 Apr 25
Fair value Increased 6.51%

Shared on09 Apr 25
Fair value Increased 1.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 5.69%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.